参考文献:1.van Adrichem EJ, Meulenbroek RL, Plukker JTM et al (2014) Comparison of two preoperative inspiratory muscle training programs to prevent pulmonary complications in patients undergoing esophagectomy: a randomized controlled pilot study. Ann Surg Oncol 21:2353鈥?360PubMed 2.Agrelli TF, de Carvalho Ramos M, Guglielminetti R et al (2012) Preoperative ambulatory inspiratory muscle training in patients undergoing esophagectomy. A pilot study. Int Surg 97:198鈥?02PubMedCentral CrossRef PubMed 3.Barkun AN, Bardou M, Martel M et al (2010) Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointest Endosc 72:1138鈥?145CrossRef PubMed 4.Bhatti AB, Rizvi FH, Waheed A et al (2015) Does prior percutaneous endoscopic gastrostomy alter post-operative outcome after esophagectomy. World J Surg 39:441鈥?45CrossRef PubMed 5.Biere SS, van Berge Henegouwen MI, Maas KI et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-labeled, randomized controlled trial. Lancet 379:1887鈥?892CrossRef PubMed 6.Bokemeyer C, Aapro MS, Courdi A et al (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40:2201鈥?216CrossRef PubMed 7.Changela K, Papafragkakis H, Ofori E et al (2015) Hemostatic powder spray: a new method for managing gastrointestinal bleeding. Therap Adv Gastroenterol 8:125鈥?35PubMedCentral CrossRef PubMed 8.Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11鈥?0CrossRef PubMed 9.Dai Y, Li C, Xie Y et al (2014) Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 10:CD005048. (John Wiley & Sons, Ltd)PubMed 10.Derogar M, Orsini N, Sadr-Azodi O et al (2012) Influence of major postoperative complications on Health-Related Quality of Life among long-term survivors of esophageal cancer surgery. J Clin Oncol 30:1615鈥?619CrossRef PubMed 11.Dettling DS, van der Schaaf M, Blom RLGM et al (2013) Feasibility and effectiveness of pre-operative inspiratory muscle training in patients undergoing oesophagectomy: a pilot study. Physiother Res Int 18:16鈥?6CrossRef PubMed 12.Feeney C, Reynolds JV, Hussey J (2011) Preoperative physical activity levels and postoperative pulmonary complications post-esophagectomy. Dis Esophagus 24:489鈥?94CrossRef PubMed 13.van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074鈥?084CrossRef PubMed 14.Inoue J, Ono R, Makiura D et al (2013) Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus 26:68鈥?4CrossRef PubMed 15.Kim YI, Choi IJ (2015) Endoscopic management of tumor bleeding from inoperable gastric cancer. Clin Endosc 48:121鈥?27PubMedCentral CrossRef PubMed 16.Kim YI, Choi IJ, Cho SJ et al (2013) Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer. J Gastroenterol Hepatol 28:1489鈥?495CrossRef PubMed 17.Leers JM, Vivaldi C, Schafer H et al (2009) Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent. Surg Endosc 23:2258鈥?262CrossRef PubMed 18.Loprinzi CL, Qin R, Dakhil SR et al (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol 32:997鈥?005PubMedCentral CrossRef PubMed 19.Lordick F, Hoffmeister A (2014) [Treatment of gastric cancer]. Internist (Berl) 55:15鈥?2CrossRef 20.Lordick F, H枚lscher AH, Haustermans K, Wittekind C (2013) Multimodal treatment of esophageal cancer. Langenbecks Arch Surg 398:177鈥?87CrossRef PubMed 21.Lordick F, Gockel I, Wittekind C (2015) Magenkarzinom: Neue molekulare Konzepte. Dtsch Arztebl 112:[4]. doi:10.鈥?238/鈥婸ersOnko.鈥?015.鈥?5.鈥?5.鈥?1 22.Lorenzen S, Sp枚rl S, Lordick F (2014) [Incidence and treatment of chemotherapy-induced nausea and emesis in gastrointestinal cancer]. Z Gastroenterol 52:821鈥?30CrossRef PubMed 23.Lorenzen S, Thuss-Patience P, Al-Batran SE et al (2013) Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy. Ann Oncol 24:2068鈥?073CrossRef PubMed 24.Mariette C, Gronnier C, Duhamel A et al (2015) Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. J Am Coll Surg 220:287鈥?96CrossRef PubMed 25.Nevler A, Gluck I, Balint-Lahat N et al (2014) Recurrent metastatic spread to a percutaneous gastrostomy site in a patient with squamous cell carcinoma of the tongue: a case report and review of the literature. J Oral Maxillofac Surg 72:829鈥?32CrossRef PubMed 26.Okines AFC, Langley RE, Thompson LC et al (2013) Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report. Ann Oncol 24:702鈥?09CrossRef PubMed 27.Pfirrmann D, Botzenhardt S, Brosteanu O et al (2015) Internet-based perioperative sports program in patients with Barrett鈥檚 carcinoma scheduled for esophagectomy (IPSP-Study). A prospective randomized-controlled trial. BMC Cancer [submitted] 28.Ren Z, Zhu K, Kang H et al (2015) Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol 33:894鈥?00CrossRef PubMed 29.Schuhmacher C, Gretschel S, Lordick F et al (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28:5210鈥?218PubMedCentral CrossRef PubMed 30.Sheibani S, Kim JJ, Chen B et al (2013) Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy. Aliment Pharmacol Ther 38:144鈥?50CrossRef PubMed 31.Smith EML, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359鈥?367PubMedCentral CrossRef PubMed 32.Smith TJ, Khatcheressian J, Lyman GH et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187鈥?205CrossRef PubMed 33.Stahl M, Stuschke M, Lehmann L et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310鈥?317CrossRef PubMed 34.Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 29:1715鈥?721 35.Strand DS, Thlick JEC, Patrie JT et al (2012) Gastroduodenal stents are associated with more durable patency as compared to percutaneous endoscopic gastrojejunostomy in the palliation of malignant gastric outlet obstruction. J Inter Gastroenterol 2:150鈥?54CrossRef 36.Tatematsu N, Park M, Tanaka E et al (2013) Association between physical activity and postoperative complications after esophagectomy for cancer: a prospective observational study. Asian Pac J Cancer Prev 14:47鈥?1CrossRef PubMed 37.Valkenet K, Trappenburg JCA, Gosselink R et al (2014) Preoperative inspiratory muscle training to prevent postoperative pulmonary complications in patients undergoing esophageal resection (PREPARE study): study protocol for a randomized controlled trial. Trials 15:144PubMedCentral CrossRef PubMed 38.Valkenet K, van de Port IGL, Dronkers JJ et al (2011) The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 25:99鈥?11CrossRef PubMed 39.Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715鈥?721CrossRef PubMed
作者单位:Prof. Dr. I. Gockel MBA (1) A. Hoffmeister (2) F. Lordick (3)
1. Klinik f眉r Viszeral-, Transplantations-, Thorax- und Gef盲脽chirurgie, Department f眉r Operative Medizin (DOPM), Universit盲tsklinikum Leipzig, Liebigstr. 20, 04103, A枚R, Leipzig, Deutschland 2. Klinik f眉r Gastroenterologie, Universit盲tsklinikum Leipzig, A枚R, Leipzig, Deutschland 3. Universit盲res Krebszentrum Leipzig (UCCL), Universit盲tsklinikum Leipzig, A枚R, Leipzig, Deutschland